Rohit Gupta

What Rohit is building in 2026

Rohit's 2026 focus is the production-scale deployment of three AI-first platforms ICG has built for healthcare and pharma: Hawk (Healthcare AI With Keystone — Device-ID-based attribution and unified CRM for healthcare brands), YODA (YouTube Optimization & Decision Analytics — the YouTube intelligence layer powering ICG's YouTube-led acquisition programmes), and Pharos (the 9-module pharma platform covering scientific writing, pharmacovigilance, MR field-force operations, and pre-promotional content governance).

The architecture decision Rohit drove in 2026 is the Device-ID-first attribution layer. Traditional healthcare attribution depends on cookies, pixel tracking, and platform self-reporting — each of which is now structurally compromised by browser privacy changes, ad-blocker prevalence, and DPDP Act 2023 consent requirements. Hawk's Device-ID infrastructure side-steps the cookie problem entirely by using cookie-independent device fingerprinting that is DPDP-compliant by design and platform-agnostic by construction. The result: every patient touch is captured, every channel's actual contribution is measurable, and every healthcare brand running on Hawk gets ROI clarity that platform self-reporting cannot deliver.

The second Rohit-led architecture decision in 2026 is the GEO measurement layer — making ChatGPT, Perplexity, Claude, and Gemini brand-mention measurement a first-class data stream alongside Google Search Console. The measurement stack tracks ~100 healthcare query patterns per client per week across all four LLM surfaces, capturing brand-mention frequency, citation context, and competitive positioning. The output is reported in monthly client reviews alongside Google ranking data — the first integrated measurement of healthcare brand visibility across search and AI-search surfaces.

Rohit's IIT BHU pharmaceutical engineering background continues to shape ICG's pharma work. The Pharos platform's compliance encoding (UCPMP 2024, GVP IX, MDR 2017, EU MDR 2017/745, Schedule J, Schedule Y, Drugs and Magic Remedies Act 1954) is rigorous because the team understands the regulatory frameworks at the level of the pharmaceutical engineer who has worked with them.

Rohit Gupta is Co-Founder and Director at Ichelon Consulting Group (ICG), where he leads AI product development, business growth infrastructure, and technology architecture across 150+ active healthcare client engagements.

His specific expertise sits at the intersection of performance marketing architecture and operational effectiveness — the point where paid media signal quality meets the telecalling conversion process. This is the seam most agencies do not cross. ICG's entire framework set lives there.

What Rohit built at ICG

Rohit architected ICG's SLC Matrix (Service × Location × Channel — the foundation of every channel selection decision), the DCG Matrix for Google Ads (an 11-point diagnostic + cost wastage + growth framework), the CBO Tool for crawl budget optimisation, and the Device ID Tool for cross-session attribution.

He led the construction of ICG's three proprietary platforms in production today:

• Beacon — CAPI middleware that raises Meta Event Match Quality from the healthcare-industry-average 2.5 to 6.0–8.0, enabling Smart Bidding to optimise correctly.
• Agency OS — the live multi-account dashboard unifying Google Search Console, GA4, Google Ads, Meta Ads, and IVR call data into a single source of truth.
• Phoenix — clinic revenue intelligence layered over existing PMS systems, currently rolled out across 46 healthcare centres.

The diagnostic mindset

Rohit personally leads every Brand & Growth Diagnostic call for performance marketing clients — the 30-minute working session that ICG runs before any engagement begins. The discipline he brings: root cause first, solution second. He has run this same diagnostic conversation more than 400 times across IVF, dermatology, hair transplant, plastic surgery, ophthalmology, dental, and multi-specialty hospital contexts.

The pattern Rohit returns to in every diagnostic: "A high CPL is almost never a creative problem. It is a channel selection, keyword architecture, or audience segmentation problem. Creative is the last lever to pull — not the first."

Research, publications & speaking

• Author: ICG IVF Marketing Insights Report 2025 (10,000+ patient dataset, 5 Indian states)
• Author: ICG Patient Lifecycle Research 2026 — the 67% AI-adoption finding
• Speaker: Aarambh AI Healthcare Summit 2026
• Speaker & moderator: Bihar AI Summit 2026 (2,000+ attendees, government-convened)
• Regular contributor: ICG Insights on healthcare AI and growth architecture

Background

IIT BHU (B.Tech + M.Tech). IIM Rohtak. Eight years in healthcare marketing. Based in Gurgaon, where ICG's headquarters operates from JMD Megapolis, Sector 48.

"The brains behind the company — Mr. Abhash, Mr. Rohit, Mr. Deep — are all very talented IIT-IIM alumni with wonderful insights on how to scale a healthcare business."
— Dr. Samyak Dhawan, Kayakalp Global